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Adequate  maternal  behavior  in rats  requires  minimal  corticotropin-releasing  factor  receptor  (CRF-R)  acti-
vation  in  the  medial-posterior  bed  nucleus  of the stria terminalis  (mpBNST).  Based  on the architectural
heterogeneity  of  the  BNST  and  its distinct  inter-neural  connectivity,  we  tested  whether  CRF-R  manipu-
lation  in  another  functional  part,  the  anterior-dorsal  BNST  (adBNST),  differentially  modulates  maternal
behavior.
We demonstrate  that in the  adBNST,  activation  of  CRF-R1  reduced  arched  back  nursing  (ABN)  and  nurs-
ing,  whereas  activation  of  CRF-R2  resulted  in an  initial  reduction  in nursing  but  signiﬁcantly  increased  the
incidence  of  ABN  5 h  after  the  treatment.  Following  stressor  exposure,  which  is detrimental  to  maternal
care,  ABN  tended  to be protected  by CRF-R1  blockade.  Maternal  motivation,  maternal  aggression,  and
anxiety  were  unaffected  by any  manipulation.  Furthermore,  under  basal  and  stress  conditions,  activation
of  adBNST  CRF-R1  increased  plasma  ACTH  and  corticosterone  concentrations,  whereas  stimulation  of
adBNST  CRF-R2  increased  basal  plasma  ACTH  and  corticosterone  concentrations,  but blocked  the  stress-
induced  increase  in  plasma  corticosterone  secretion.  Moreover,  both  the  CRF-R1  and  -R2  antagonists
prevented  the  stress-induced  increase  in plasma  corticosterone  secretion.  Importantly,  elevated  lev-
els  of circulating  corticosterone  induced  by intra-adBNST  administration  of  CRF-R1  or -R2 agonist  did
not  impact  maternal  care.  Finally,  Crf  mRNA  expression  in the  adBNST  was  increased  during  lactation;
however,  Crfr1  mRNA  expression  was  similar  between  lactating  and  virgin  rats.
In  conclusion,  maternal  care  is  impaired  by  adBNST  CRF-R1  activation,  and  this  appears  to  be  the  result
of  a  central  action,  rather  than  an  effect  of  elevated  circulating  levels  of CORT.  These  data  provide  new
insights  into  potential  causes  of disturbed  maternal  behavior  postpartum.
© 2015  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license. Introduction
The peripartum period is accompanied by numerous physiolog-
cal and behavioral adaptations organized by the maternal brain.
hese changes are essential for the adequate expression of maternal
ehavior, thereby ensuring the proper development of the off-
pring, as well as for the mothers’ mental health. Indeed, up to 30%
f mothers that develop postpartum mood disorders show child
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306-4530/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article u(http://creativecommons.org/licenses/by/4.0/).
neglect, with some committing infanticide (Brummelte and Galea,
2010b; Friedman and Resnick, 2009).
One peptidergic system that evidently contributes to such
maladaptations during this highly sensitive period is the central
corticotropin-releasing factor (CRF) system (Klampﬂ et al., 2014,
2013; Magiakou et al., 1996). The CRF system consists of CRF and
its related peptides, urocortin 1, 2 and 3, which bind to CRF receptor
type 1 (CRF-R1), CRF-R2, and the CRF binding protein with different
afﬁnities (Reul and Holsboer, 2002). CRF was ﬁrst discovered as the
main initiator of the hypothalamic–pituitary–adrenal (HPA) axis
and is the major secretagogue of ACTH from the anterior pituitary
into the portal blood system (Vale et al., 1981). ACTH stimulates
the release of corticosterone (CORT) from the adrenal glands which
plays several roles in mediating appropriate responses to stress and
also exerts negative feedback control of the HPA axis at the level
of the hippocampus, paraventricular nucleus (PVN), and pituitary.
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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oreover, CRF and its related peptides also exert central functions
nd inﬂuence a variety of non-social and social behaviors, e.g.,
ncreased anxiety-related behavior (Britton et al., 1986; Klampﬂ
t al., 2014, 2013; Sahuque et al., 2006) and reduced maternal
ehavior (Gammie et al., 2004; Klampﬂ et al., 2014, 2013; Pedersen
t al., 1991), even leading to pup killing in virgin rats (Pedersen
t al., 1991). Intriguingly, some of these effects can be attributed
o the CRF system of the bed nucleus of the stria terminalis (BNST)
Klampﬂ et al., 2014; Sahuque et al., 2006).
The BNST is a complex and particularly heterogeneous structure
ithin the limbic system. It acts as a central relay site for the inte-
ration of a variety of neuronal signals, mediating behavioral as well
s physiological responses. The BNST can be roughly divided into
nterior and posterior divisions. The anterior part is mainly con-
ected with hypothalamic and brainstem regions associated with
utonomic activity (Dong et al., 2001a), while the posterior divi-
ion is involved in controlling neuroendocrine systems and social
ehaviors (Dong et al., 2001a; Dong and Swanson, 2004). Such het-
rogeneity within a single brain region raises the question whether
ocial (e.g., maternal behavior) and non-social behaviors (e.g., anx-
ety) might be differentially regulated within the BNST depending
n the speciﬁc subdivision.
We have recently demonstrated that reduced activation of the
RF-R within the medial-posterior BNST (mpBNST) is necessary for
he optimal expression of maternal behavior postpartum (Klampﬂ
t al., 2014). Thus, in the present study we focused on the role
f the CRF system in the anterior-dorsal BNST (adBNST) contain-
ng the oval, anterodorsal, anterolateral and juxtacapsular nuclei
Fig. 1) (Dong et al., 2001b) in regulating maternal and anxiety-
elated behavior in lactating rats. We  acutely manipulated the
RF-R1 and -R2 in the adBNST with receptor-selective agonists
nd antagonists and assessed the effects on maternal care, mater-
al motivation, maternal aggression, and anxiety-related behavior
uring early lactation. Furthermore, we investigated the impact
f acute intra-adBNST CRF-R manipulation on HPA axis activity
nder both basal and stressful conditions to determine whether the
hysiological changes observed might account for the changes in
aternal behavior. Finally, we compared mRNA expression of the
rf gene and its receptors in virgin and lactating rats in the adBNST
nd additionally the anterior-ventral BNST (avBNST; Fig. 1), which
ppears to be also involved in the regulation of maternal behavior
Smith et al., 2012).
. Materials & methods
.1. Animals
Virgin female Sprague-Dawley rats (220–250 g; Charles River
aboratories, Sulzfeld, Germany) were kept under standard labo-
atory conditions (change of bedding once per week, RT 22 ± 2 ◦C,
5% relative humidity, 12:12 h light/dark cycle, lights on at 0600 h)
ith access to water and standard rat chow ad libitum. Females
ere mated with experienced stud males, and housed in groups of
–4 until pregnancy day 18. For experiment 1, females underwent
urgery on pregnancy day 18 and were single-housed thereafter
o guarantee recovery and undisturbed delivery, and for exper-
ment 2, 3 and 4, females were single-housed from pregnancy
ay 18 to guarantee undisturbed delivery as described recently
Bayerl et al., 2014; Klampﬂ et al., 2013). On the day of birth, lit-
ers were culled to eight pups of mixed sexes. For experiment 4,
irgin females and lactating rats were treated identically, i.e., vir-
ins were single-housed 7 days prior to brain collection, consistent
ith the single-housing period of the lactating rats. During the
ingle-housing period (except the day before and the day of deliv-ocrinology 64 (2016) 89–98
ery), all rats were handled twice a day to reduce non-speciﬁc stress
responses during the experiments.
For the maternal defense test, naïve virgin female Wistar rats
(200–220 g, Charles River Laboratories) selected at random stages
across the estrus cycle were used as intruders. Intruder rats were
housed in a separate room to avoid olfactory recognition (Bosch,
2013).
All experiments were approved by the Committee on Animal
Health and Care of the local government and conformed to inter-
national guidelines on the ethical use of animals. Efforts were made
to minimize the number of rats used and their suffering.
2.2. Behavioral tests
All tests were analyzed online (maternal care, pup retrieval test
(PRT), elevated plus-maze (EPM)) or from video recordings (mater-
nal defense test; http://www.jwatcher.ucla.edu) by an experienced
observer blind to the treatments.
2.2.1. Maternal care
Maternal care was monitored according to an established pro-
tocol (Klampﬂ et al., 2014). Brieﬂy, maternal care was observed
before and after treatment, i.e., either substance infusion alone
termed ‘non-stress condition’ or substance infusion followed by
the maternal defense test, which is a psycho-social stressor
(Neumann et al., 2001), termed ‘stress condition’ (Bayerl et al.,
2014; Klampﬂ et al., 2014, 2013). The main parameter for the qual-
ity of maternal care was the occurrence of arched back nursing
(ABN) (Bosch, 2011). Other behavioral parameters scored were hov-
ering over the pups and blanket nursing posture, which together
with ABN were counted as total nursing (quantity of maternal
care). Pup retrieval/mouthing and licking/grooming were assessed
as ‘other maternal behaviors’. Additionally, non-maternal (‘off-
nest’) behaviors were scored, i.e., locomotion, self-grooming, and
sleeping/resting. Data is shown in 30 min  blocks before and after
treatment infusion with a maximal count of 15 observations per
block.
2.2.2. Maternal motivation
The dams’ maternal motivation was  tested in the PRT (Klampﬂ
et al., 2014). Brieﬂy, after 60 min  of pup separation, the dam was
placed in a plastic box (54 cm × 34 cm × 31 cm)  and the number of
retrieved pups within the 15-min testing period was counted.
2.2.3. Maternal aggression
To assess maternal aggression, the maternal defense test was
performed (Klampﬂ et al., 2014; Neumann et al., 2001). Brieﬂy, the
lactating dams (residents) were confronted with an unknown vir-
gin female (intruder) in the dams’ home cage in the presence of their
litter for 10 min. The following behavioral parameters were scored:
total number of attacks, latency to ﬁrst attack, lateral threat, keep
down, and offensive upright as well as non-aggressive behaviors
(for detailed description see (Bosch, 2013)).
2.2.4. Anxiety-related behavior
Anxiety-related behavior was tested on the EPM (Klampﬂ et al.,
2014; Pellow et al., 1985). Brieﬂy, the dams were placed in the
neutral zone of the maze and scored for 5 min. The percentage
of time spent on the open arms versus all arms and of open arm
entries versus all entries were taken as indicator of anxiety-related
behavior. The number of closed arm entries was  used to measure
locomotion.
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.3. Experimental design
Schematic overviews of the timelines used for experiments 1–4
re shown in Fig. S1.
.3.1. Experiment 1: behavioral consequences of intra-adBNST
anipulation of CRF-R1 or -R2 on maternal behavior
Experiment 1 was conducted according to an established pro-
ocol (Klampﬂ et al., 2014). Brieﬂy, on PD 18, females were
mplanted bilaterally with 23 G guide cannula targeting the
dBNST (−0.2 mm caudal, 3.0 mm lateral, 4.9 mm ventral to bregma
Paxinos and Watson, 1998); angle of 12.5◦) under inhalation
nesthesia (Isoﬂurane; Baxter Germany GmbH, Unterschleißheim,
ermany) and semi-sterile conditions (Bosch et al., 2010). Sub-
tances were infused using a 27 G infusion cannula. Lactating
ats received either (i) VEH (0.5 l of sterile Ringer’s solution
4% DMSO; pH 7.4; B. Braun Melsungen, Melsungen, Germany),
ii) CRF-R1 agonist, human/rat CRF (1 g/0.5 l; Tocris Bioscience,
llisville, Missouri, USA), (iii) CRF-R1 speciﬁc antagonist, CP-
54,526 (12 g/0.5 l; Tocris Bioscience), (iv) CRF-R2 speciﬁc
gonist, hUcn 3 (stresscopin; 3 g/0.5 l; Phoenix Pharmaceuticals,
arlsruhe, Germany), or (v) CRF-R2 speciﬁc antagonist (astressin-
B; 4 g/0.5 l; Sigma–Aldrich, Steinheim, Germany). Stresscopin
as previously been shown to be highly selective for CRF-R2, and is
ithout effect on CRF-R1 expressing cells (Hsu and Hsueh, 2001).
oses and the lag time between the infusion and behavioral test-
ng were chosen based on previous studies (D’Anna and Gammie,
009; D’Anna et al., 2005; Gammie et al., 2004; Klampﬂ et al., 2014;
ahuque et al., 2006). On each test day, the lactating dams received
 single acute bilateral infusion either 10 min  (VEH, CRF-R1 agonist,
RF-R1 antagonist, CRF-R2 antagonist) or 25 min  (CRF-R2 agonist)
rior to the tests. Each animal received the same treatment on every
esting day as assigned on LD 1. Importantly, the repeated infusions
f the CRF-R1 or -R2 (ant-) agonists separated by 48 h intervals are
ot expected to result in receptor (de)sensitization (Hauger et al.,
009; Klampﬂ et al., 2014; Spiess et al., 1998).
Maternal care was observed under non-stress conditions (LD
) and stress conditions (LD 7) in the home cage. Under non-stress
onditions, dams were observed from 0800 h to 0900 h, received an
nfusion and were observed immediately afterwards for 120 min.
dditionally, dams were observed again 5 h after infusion, from
400 h to 1500 h, to assess potential long-lasting effects of drug
reatment. Under stress conditions, dams were observed from
800 h to 0900 h, moved to the test room, and infused at 1000 h.
ams were tested in the maternal defense test, and immediately
fterwards moved back to the observation room, where maternal
ig. 1. Histological localization of infusion cannula within the adBNST.
istological deﬁnition of the adBNST containing a variety of subnuclei according to Don
tlas  (Paxinos and Watson, 1998). For better visualization purposes, correct cannula place
re  shown unilaterally.
c: anterior commissure, ad: anterodorsal BNST, al: anterolateral BNST, av: anterior-vent
entral  division, lv: lateral ventricle, ov: oval nucleus of the BNST.ocrinology 64 (2016) 89–98 91
care was  observed for another 60 min  in order to assess the effects
of the preceding stressor on maternal care. Additionally, maternal
motivation (LD 3), anxiety-related behavior (LD 5), and maternal
aggression (LD 7) were tested as described above. All tests were
performed between 0800 h and 1500 h.
2.3.2. Experiment 2: effect of intra-adBNST manipulation of
CRF-R1 or -R2 on basal and stress-induced HPA axis activity
On LD 1, separate groups of rats were bilaterally implanted
with a local guide cannula targeting the adBNST as described in
Section 2.3.1. In order to determine HPA axis activity following
intra-adBNST CRF-R manipulations, dams were also ﬁtted with a
jugular vein catheter for repeated blood sampling in conscious,
freely moving rats, as previously described (Bosch et al., 2007).
On LD 6 at 0800 h, the catheters were connected to a sam-
pling syringe ﬁlled with heparinized saline (0.6%; Ratiopharm, Ulm,
Germany). After 90 min  of habituation, blood samples (0.25 ml)
were collected into EDTA-coated tubes and stored on ice. The ﬁrst
two samples were withdrawn 30 min  apart under basal condi-
tions. Immediately afterwards, the dams were infused bilaterally
into the adBNST with VEH, CRF-R1 agonist, CRF-R2 agonist, CRF-
R1 antagonist, or CRF-R2 antagonist (drug details and doses are
given in Section 2.3.1). Further blood samples were collected 10
and 30 min after the treatment to assess the effect of speciﬁc CRF-R
activation/inhibition on HPA axis activity. Thirty minutes after the
drug infusion, dams were exposed to the maternal defense test for
10 min  (see Section 2.2.3). Additional blood samples were collected
5, 15, and 60 min  after termination of the stressor exposure. All
blood samples were immediately replaced with 0.9% sterile saline.
Samples were centrifuged for 15 min  at 4 ◦C (5000 rpm) and stored
at −20 ◦C until further processing.
Plasma ACTH (sensitivity: 0.22 pg/ml; intra-assay and inter-
assay coefﬁcients of variation were ≤7.1%) and CORT (sensitivity:
<0.56 ng/ml; intra-assay and inter-assay coefﬁcients of variation
≤6.35%) concentrations were measured using commercially avail-
able ELISA kits (IBL International GmbH, Hamburg, Germany).
2.3.3. Experiment 3: behavioral consequences of HPA axis
activation on maternal care
In order to investigate a potential inﬂuence of HPA axis activa-
tion on maternal care, a separate cohort of lactating rats was ﬁtted
with a jugular vein catheter for i.v. injection on LD 1 (for details see
Section 2.3.2).
On LD 6, the catheters were connected at 0800 h and the dams
were left undisturbed for 120 min. Between 0900 h and 1000 h, the
occurrence of maternal care was  observed under basal conditions
g et al. (2001b) shown on schematic plates adapted from the stereotaxic rat brain
ment sites (black dots) for subsequent drug infusion in the adBNST (light gray area)
ral BNST, f: fornix, ic: internal capsule, ju: juxtacapsular BNST, LSv: lateral septum
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Fig. 2. Effect of intra-adBNST CRF-R1 or -R2 speciﬁc agonist (ago) or antagonist (ant)
treatment on maternal care of lactating dams under non-stress conditions on LD 1.
Arched back nursing (ABN; A, B) and total nursing (C, D) were scored for 60 min
before, for 90 min  after infusion and for additional 60 min  following a 5 h delay.
The data collected during the 90 min  period after the drug infusion are summed
up and shown on the right side (B, D). Dams received an acute bilateral infusion
of either (i) vehicle (VEH), (ii) a CRF-R1 ago (CRF), (iii) a CRF-R1 ant (CP-154,526),
(iv)  a CRF-R2 ago (stresscopin), or (v) a CRF-R2 ant (astressin-2B) into the adBNST.
Data is presented as group means + SEM. n = 6–8 rats per group. **p ≤ 0.01, *p ≤ 0.052 S.M. Klampﬂ et al. / Psychone
s described in Section 2.2.1. At 1000 h, dams were acutely infused
.v. via the catheter with either 100 l 0.9% sterile saline (VEH)
r 100 l ACTH(1–39) (mouse, rat; 0.1 g/ml; Bachem, Bubendorf,
witzerland) and observed for another 120 min  to assess any poten-
ial inﬂuences of ACTH infusion (and hence acutely elevated CORT
evels) on maternal care.
In order to verify a physiological CORT response following acute
CTH infusion, the catheters of the same rat cohort were connected
n LD 7 at 0800 h and blood samples were withdrawn as described
n Section 2.3.2. The ﬁrst two samples were withdrawn 30 min  apart
nder basal conditions. Immediately afterwards, the dams were
nfused i.v. via the catheter according to LD 6. In addition, a third
aïve group was subjected to a 10-min maternal defense test in
rder to compare the endogenous HPA axis response (Neumann
t al., 2001) to the ACTH-induced stress response. Further blood
amples were collected 5, 15 and 60 min  after injection/stressor
xposure. All blood samples were treated and analyzed as described
n Section 2.3.2. The dose of ACTH was based on a preliminary study
Perani et al., 2015).
.3.4. Experiment 4: expression of Crf and Crfr mRNA in the
nterior BNST of virgin and lactating rats
In order to compare the effect of reproductive status on Crf,  Crfr1
nd Crfr2 mRNA expression in the adBNST, a separate cohort of
aïve, untreated virgin and lactating rats was killed under basal
onditions in the morning of LD 4 or equivalent in virgin rats, i.e.,
fter 7 days of single-housing. The brains were rapidly removed,
ash frozen on dry ice, and stored at −20 ◦C until further processing
see Section 2.4).
.4. In situ hybridization for Crf and Crfr mRNA expression
Frozen brains were sectioned at 16 m using a cryostat
Model CM3050S Leica Microsystems GmbH, Nussloch, Germany),
ounted on polysine slides, and stored at −20 ◦C until further pro-
essing.
Crf mRNA in situ hybridization was conducted following an
stablished protocol using a highly-speciﬁc 48-base, 3′-end 35S-
abeled oligonucleotide probe (De Vries et al., 1994; Wang et al.,
994). Crfr1 and Crfr2 mRNA in situ hybridization was performed
sing an established protocol with previously described cRNA
robes for Crfr1 and Crfr2 (Brunton et al., 2011, 2009). Autoradio-
rams of the adBNST and avBNST (Bregma +0.36 mm to −0.4 mm
Paxinos and Watson, 1998)) were analyzed with Image J (V 1.46,
IH image software) as described previously (Brunton et al., 2011;
lampﬂ et al., 2013). Measurements were made bilaterally over six
ections per rat. Brain sections hybridized with 35S-UTP-labeled
RNA sense probes (negative controls) showed no signal above
ackground.
.5. Histology
To verify the correct placements of local cannula within the
dBNST, rats were decapitated and brains were infused with 0.5 l
f ink (Pelikan Ink 4001, Hanover, Germany; diluted 1:20 in Ringer’s
olution), removed, ﬂash frozen, cut in 40 m coronal sections, and
lide mounted. Ink diffusion was only detected within the adBNST
s assessed according to our previous study (Klampﬂ et al., 2014).
dditionally, slides were stained via quick Nissl staining to locate
he tip of the infusion cannula (Fig. 1, black dots). Only rats with
orrectly located cannula and properly restricted ink diffusion were
ncluded in the statistical analysis.versus VEH-treated group; ++p ≤ 0.01, +p ≤ 0.05, (+)p = 0.07 versus t-30 min  time-
point of the same group (time course: two-way RM ANOVA; sum: one-way ANOVA),
##p  ≤ 0.01 versus VEH (independent t-test).
2.6. Statistical analysis
Behavioral and physiological data were analyzed using either
one-way analysis of variance (ANOVA; factor: treatment) or two-
way RM ANOVA (factors: time × treatment) followed by Fisher’s
LSD post hoc test for parametric data, and Kruskal–Wallis H test for
non-parametric data. In situ hybridization data was analyzed using
independent t-tests. While typically tests were performed over all
groups, only comparisons to VEH-treated rats or to basal values are
shown. For all tests, the software package SPSS 19.0 (IBM, Armonk,
New York, USA) was  used. Data are presented as means ± SEM and
signiﬁcance was accepted at p ≤ 0.05.
3. Results
3.1. Experiment 1: consequences of intra-adBNST manipulation
of CRF-R1 or -R2 on maternal behavior and anxiety
3.1.1. Maternal care under non-stress conditions
3.1.1.1. ABN. Differences in ABN were found depending on time
(two-way RM ANOVA; F(6,192) = 3.14, p < 0.01; Fig. 2A) and treat-
ment (F(4,32) = 6.62, p < 0.01), with a signiﬁcant interaction between
these factors (F(24,192) = 1.89, p = 0.01). Before the infusion, dams
treated with the CRF-R1 antagonist (p = 0.03) or CRF-R2 agonist
(p < 0.01) displayed more ABN at t-30 min  compared with the VEH
group. Immediately after the CRF-R1 agonist infusion, ABN tended
to be reduced compared with the t-30 min  time-point (p = 0.07).
Nevertheless, at t + 60 and t + 90 min  ABN was  essentially abolished
uroendocrinology 64 (2016) 89–98 93
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Fig. 3. Effect of intra-adBNST CRF-R1 or -R2 speciﬁc agonist (ago) or antagonist (ant)
treatment on maternal care of lactating dams under stress conditions on LD 7.
Arched back nursing (ABN; A, B) and total nursing (C, D) were scored for 60 min
before and after infusion combined with the maternal defense test. The 60 min  after-
wards are summed up and shown on the right side (B, D). Dams received an acute
bilateral infusion of either (i) vehicle (VEH), (ii) a CRF-R1 ago (CRF), (iii) a CRF-R1
ant (CP-154,526), (iv) a CRF-R2 ago (stresscopin), or (v) a CRF-R2 ant (astressin-S.M. Klampﬂ et al. / Psychone
n the CRF-R1 agonist-treated rats. Furthermore, ABN was  signiﬁ-
antly greater at t + 60 min  in the CRF-R1 antagonist (p < 0.01) and
RF-R2 agonist (p = 0.02) groups compared with the VEH-treated
roup. In the afternoon, both the CRF-R2 agonist (p < 0.01) and CRF-
2 antagonist (p = 0.04) groups exhibited signiﬁcantly greater ABN
ompared with the VEH-treated group.
When summing up the occurrence of ABN after the drug infu-
ion (i.e., from t + 30 min  until t + 90 min), signiﬁcant differences
ere found between the groups (one-way ANOVA, F(4,32) = 5.31,
 = 0.02; Fig. 2B). The CRF-R1 antagonist signiﬁcantly increased ABN
p = 0.02), and there was a trend toward an increase in ABN in the
RF-R2 agonist-treated group (p = 0.06). Additionally, the CRF-R1
gonist markedly decreased ABN following the infusion compared
ith the VEH-treated rats (independent t-test; t(14) = 2.95, p = 0.01).
.1.1.2. Total nursing. Differences in nursing were found depen-
ent on treatment (two-way RM ANOVA; F(4,32) = 12.18, p < 0.01;
ig. 2C) and a signiﬁcant interaction was detected between treat-
ent and time (F(24,192) = 2.20, p < 0.01). Before the drug infusion, no
ifferences were detected in total nursing. After the infusion, dams
reated with the CRF-R1 agonist showed signiﬁcantly less nursing
t t + 30 min  compared with the previous time-point (p = 0.02), as
ell as at t + 30 min, t + 60 min, t + 90 min  and t + 300 min (p < 0.01
n each case) compared with the VEH-treated rats. Dams treated
ith the CRF-R2 agonist showed reduced nursing at t + 30 min
ompared with the previous time-point and with the VEH-treated
ams (p = 0.03 in each case) as well as at t + 90 min  compared
ith VEH-treated dams (p = 0.05). When summing up the occur-
ence of total nursing after the infusion, signiﬁcant differences
ere found between the groups (one-way ANOVA; F(4,32) = 15.83,
 < 0.01; Fig. 2D). Dams treated with the CRF-R1 agonist (p < 0.01) or
RF-R2 agonist (p < 0.01) showed a signiﬁcant reduction in nursing
ompared with those treated with VEH.
There was no signiﬁcant difference in any other maternal
ehaviors measured (i.e., home cage pup retrieval/mouthing, lick-
ng/grooming) on LD1 (data not shown); however, differences in
ff-nest behavior were detected (Supplementary data and Table
1).
.1.2. Maternal care under stress conditions
.1.2.1. ABN. Time-dependent differences in ABN were found
nder stress conditions (two-way RM ANOVA; F(3,93) = 6.56,
 < 0.01; Fig. 3A). ABN was signiﬁcantly reduced in the VEH group
mmediately after termination of the stressor exposure (t 0 min
ompared to t-100 min; p < 0.01). When summing up ABN after
he drug infusion and the maternal defense test, no signiﬁcant dif-
erences were detected. However, an independent t-test revealed
 strong trend toward increased ABN in the CRF-R1 antagonist-
reated dams compared with the VEH-treated dams (t(13) = −2.00,
 = 0.06; Fig. 3B).
.1.2.2. Total nursing. Differences in total nursing were found
epending on time (two-way RM ANOVA; F(3,93) = 10.05, p < 0.01;
ig. 3C). Total nursing was reduced in the VEH- (p = 0.01), CRF-
1 antagonist- (p < 0.01) and CRF-R2 antagonist-treated groups
p = 0.03) at t 0 min  compared to t-100 min. When summing up
ursing after the infusion and the maternal defense test, no
igniﬁcant differences were found (Fig. 3D). Furthermore, no sig-
iﬁcant differences in home cage pup retrieval/mouthing and
icking/grooming were found (data not shown); however, differ-
nces were detected in non-maternal behaviors (Supplementary
ata and Table S2).2B) into the adBNST. Data presented are group means + SEM. n = 6–8 rats per group.
++p  ≤ 0.01, +p ≤ 0.05 versus t-30 min time-point of the same group (two-way RM
ANOVA); (#)p ≤ 0.06 versus VEH (independent t-test).
3.1.3. Maternal motivation
None of the treatments affected pup retrieval behavior (data not
shown).
3.1.4. Maternal aggression
None of the treatments affected aggressive or non-aggressive
behaviors in the maternal defense test (data not shown).
3.1.5. Anxiety-related behavior
None of the treatments had any signiﬁcant effect on the percent-
age of time spent on the open arms or on the number of entries into
the open or closed arms of the EPM (data not shown).
3.2. Experiment 2: effect of intra-adBNST manipulation of CRF-R1
or -R2 on HPA axis activity under basal and stressful conditions
There was a signiﬁcant effect of time (two-way RM ANOVA;
F(1.94,156) = 24.04, p < 0.01; Fig. 4 top) and treatment (F(4,26) = 16.11,
p < 0.01) and a signiﬁcant interaction between time and treatment
(F(7.8,156) = 9.26, p < 0.01; corrected after Greenhouse-Geisser) on
plasma ACTH concentrations. Dams treated with either VEH, the
CRF-R1 or the CRF-R2 agonist showed signiﬁcant changes in ACTH
levels over time (Fig. 4, top). In the VEH-treated dams, no changes
in basal plasma ACTH were found following the infusion. However,
after exposure to the maternal defense test, plasma ACTH levels
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Fig. 4. Effect of intra-adBNST CRF-R1 or -R2 speciﬁc agonist (ago) or antagonist (ant)
treatment on plasma ACTH and corticosterone (CORT) concentrations.
ACTH and CORT were measured under basal conditions (basal 1, basal 2), 10 (I + 10)
and 30 min (I + 30) after infusion, and 5 (MD  + 5), 15 (MD  + 15), and 60 min  (MD  + 60)
after  the maternal defense test. Dams received an acute bilateral infusion of either (i)
vehicle (VEH), (ii) a CRF-R1 ago (CRF), (iii) a CRF-R1 ant (CP-154,526), (iv) a CRF-R2
ago (stresscopin), or (v) a CRF-R2 ant (astressin-2B) into the adBNST. Data presented
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the maternal defense test were signiﬁcantly increased at t + 5 minre  group means + SEM. n = 5–8 rats per group. ++p ≤ 0.01, +p ≤ 0.05 versus basal 2
f  the same group; **p  ≤ 0.01, *p ≤ 0.05 versus VEH (two-way RM ANOVA).
ncreased transiently at MD + 5 compared with basal 2 (p = 0.02). In
he CRF-R1 agonist-treated dams, plasma ACTH was  signiﬁcantly
ncreased within 10 min  of the infusion and remained elevated from
asal levels at I + 30 (p < 0.01 in each case). Maternal defense had
o further effect on ACTH secretion in the CRF-R1 agonist treated
ams, with levels remaining elevated across the blood sampling
eriod (Fig. 4, top). In the CRF-R2 agonist-treated dams, ACTH secre-
ion was increased at I + 30 compared with basal 2 levels (p = 0.05),
owever, there was no further effect of stress; on the contrary,
lasma ACTH concentrations declined to levels not different from
asal levels after the maternal defense test (Fig. 4, top). No signiﬁ-
ant changes in ACTH secretion were detected in either the CRF-R1
r CRF-R2 antagonist-treated dams.
When comparing all the different treatment groups, no differ-
nces were found before the infusion, whereas the CRF-R1 agonist
nfusion resulted in signiﬁcantly greater plasma ACTH concentra-
ions at all of the time-points after the infusion compared with the
EH-treated group (p < 0.01 in each case).
There was a signiﬁcant effect of time (two-way RM
NOVA; F(3.8,186) = 21.83, p < 0.01; Fig. 4 bottom) and treat-
ent (F(4,31) = 8.46, p < 0.01) and a signiﬁcant interaction between
he factors (F(15.3,186) = 2.71, p < 0.01; corrected after Greenhouse-
eisser) on plasma CORT concentrations. All mothers, except
he CRF-R1 antagonist-treated dams, showed signiﬁcant changes
n CORT secretion over time. In the VEH-treated dams, plasma
ORT concentrations increased from basal levels after the infusion
t I + 10 (p < 0.01), plateaued and were further increased after
he maternal defense test at MD  + 5 and MD  + 15 (p < 0.01 versus
asal 2 in each case), before returning to basal levels at MD + 60.ocrinology 64 (2016) 89–98
Infusion of the CRF-R1 agonist signiﬁcantly increased plasma CORT
concentrations compared with basal levels (p < 0.01). There was  no
further increase in CORT secretion after maternal defense in the
CRF-R1 agonist-treated dams; however, plasma CORT remained
signiﬁcantly elevated above basal levels 60 min  after the stressor
exposure. In the CRF-R2 agonist-treated dams, CORT secretion
was signiﬁcantly increased after the infusion at I + 10 and I + 30
(p < 0.01 in each case) compared with basal 2 levels. However,
following stressor exposure, plasma CORT concentrations were
decreased at MD + 5 in the CRF-R2 agonist-treated dams but were
still signiﬁcantly higher than basal levels (p < 0.01). No differences
were detected at MD + 15 compared with basal levels in the CRF-R2
agonist-treated dams, however, CORT secretion increased again at
MD + 60 (p < 0.01 versus basal 2). In the CRF-R1 antagonist-treated
dams, CORT concentrations did not differ from basal at any time-
point. The CRF-R2 antagonist-treated dams showed increased
plasma CORT concentrations compared with basal levels only at
MD + 15 (p < 0.01 versus basal 2).
Comparison of the different treatment groups at the various
time-points demonstrated that all dams showed differences in
plasma CORT concentrations after drug infusion compared with
VEH-treated rats. Infusion of the CRF-R1 agonist resulted in a sig-
niﬁcantly greater increase in CORT secretion at I + 30 (p < 0.01),
with plasma CORT concentrations remaining elevated at MD  + 15
(p = 0.02) and MD + 60 (p < 0.01). The CRF-R1 antagonist prevented
the stress-induced increase in CORT secretion at MD + 15 observed
in the VEH-treated dams (p < 0.01 versus VEH). Infusion of the CRF-
R2 agonist signiﬁcantly increased circulating CORT concentrations
at I + 30 (p = 0.02); however, after exposure to the maternal defense
test, CORT secretion decreased at MD + 15 (p = 0.01), before rising
again at MD + 60 (p = 0.01). Infusion of the CRF-R2 antagonist had
no signiﬁcant effect on basal CORT secretion; however, it did pre-
vent the stress-induced increase in CORT secretion observed in
the VEH-treated dams (I + 10: p = 0.02; MD + 5: p = 0.02; MD  + 15:
p = 0.03 versus VEH).
3.3. Experiment 3: behavioral consequences of HPA axis
activation on maternal care
3.3.1. Maternal care after i.v. VEH or ACTH infusion
On LD 6, infusion of VEH or ACTH did not alter any parameter of
maternal care (Supplementary data and Table S3).
3.3.2. Plasma ACTH and CORT concentrations following i.v. ACTH
infusion or stressor exposure
There was a signiﬁcant effect of time (two-way RM ANOVA;
F(4,64) = 14.49, p < 0.01) but not of treatment, and a signiﬁcant
interaction between time and treatment on plasma ACTH con-
centrations (F(8,64) = 10.54, p < 0.01; Fig. 5 top). As expected, the
ACTH infusion signiﬁcantly increased plasma ACTH concentrations
at t + 5 min  compared with basal levels and with the VEH-treated
group (p < 0.01 in each case); with levels returning to basal by
t + 15 min. The maternal defense test signiﬁcantly increased ACTH
secretion at t + 5 min  (p = 0.04 versus basal 2) and t + 15 min (p < 0.01
versus basal 2, p = 0.01 versus VEH).
There was a signiﬁcant effect of time (two-way RM ANOVA;
F(4,80) = 10.44, p < 0.01) but not of treatment, and a signiﬁcant inter-
action between time and treatment on plasma CORT concentrations
(F(8,80) = 6.15, p < 0.01; Fig. 5 bottom). Plasma CORT concentra-
tions in both the ACTH-treated dams and the dams exposed toand t + 15 min  compared with basal concentrations (p < 0.01 in
each case), before declining to basal levels at t + 60 min. Moreover,
CORT secretion was signiﬁcantly greater in the ACTH-treated and
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Fig. 5. Effect of i.v. ACTH infusion or exposure to the maternal defense (MD) test on
plasma ACTH and corticosterone (CORT) concentrations.
ACTH and CORT were measured under basal conditions (basal 1, basal 2) and 5, 15,
and 60 min after infusion or exposure to the MD test. Dams received an acute i.v.
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Fig. 6. Crf and Crfr1 mRNA expression in the adBNST and avBNST of virgin and lac-
tating rats under non-stress conditions.
Quantiﬁcation of (A) Crf mRNA and (B) Crfr1 mRNA presented as gray density (A) or
grain area (mm2/mm2; B). (C) Representative brightﬁeld photomicrographs of Crfr1
mRNA expression in the avBNST from (i) a virgin and (iii) a lactating rat, (ii) and (iv)
are  high power images of the area delineated by the box in (i) and (iii), respectively.
Arrows indicate examples of positively hybridized cells from a virgin (open arrows)
and a lactating rat (ﬁlled arrows). ac, anterior commissure; scale bars: 200 m,  uppernfusion of vehicle (VEH) or ACTH(1–39). Data presented are group means + SEM.
 = 6–9 rats per group. **p ≤ 0.01, *p ≤ 0.05 versus VEH; ++p ≤ 0.01, +p ≤ 0.05 versus
asal 2 of the same group (two-way RM ANOVA).
aternal defense-exposed dams at t + 15 min  compared with the
EH-treated rats (p < 0.01 in each case).
.4. Experiment 4: Crf and Crfr mRNA expression in the anterior
NST of virgin and lactating rats
Crf mRNA expression was signiﬁcantly greater in the adBNST
independent t-test; t(12) = −2.20, p = 0.04) and tended to also be
reater in the avBNST (t(12) = −1.92, p = 0.07) of lactating rats com-
ared with virgin rats (Fig. 6A).
Crfr1 mRNA expression was similar in the adBNST, though there
as a tendency for reduced expression in the avBNST (independent
-test; t(11) = 1.96, p = 0.07) of lactating rats compared with virgin
ats (Fig. 6B, c). Crfr2 mRNA expression was not detected in the
dBNST or the avBNST of virgin or lactating rats, consistent with
revious reports in males and virgin females (Van Pett et al., 2000).
. Discussion
The activity of the maternal brain’s CRF system is attenuated
o ensure appropriate maternal behavior (Gammie et al., 2004;
lampﬂ et al., 2013; Pedersen et al., 1991). The BNST represents
 major regulatory site, as activation of predominantly CRF-R2 in
he mpBNST results in maternal neglect (Klampﬂ et al., 2014). Here,
e provide evidence that the CRF system in the adBNST exerts
istinct and more selective roles in modulating maternal behav-
or. Activation of CRF-R1 in the adBNST reduced maternal care but
ot maternal motivation, aggression or anxiety in lactating rats.panels; 100 m,  lower panels. Data presented are group means ± SEM. n = 6–7 rats
per group. *p < 0.05, (*)p = 0.07 (independent t-test).
Importantly, these effects appear to be mediated independent of
simultaneous HPA axis activation.
Under basal conditions, CRF-R1 activation in the
adBNST impaired nursing, suggesting CRF-R1 stimulation during
lactation leads to neglect of the offspring. CRF-R2 activation in the
adBNST resulted in increased ABN after a 5 h delay, which probably
compensates for the initial decline in nursing. In contrast to the
current study, CRF-R2 activation in the mpBNST is detrimental to
ABN (Klampﬂ et al., 2014), indicating that potential diffusion from
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he adBNST to the mpBNST is unlikely. Moreover, we  found that
RF-R2 activation decreased the occurrence of total nursing imply-
ng that the CRF-R2 agonist-treated dams nurse less promptly
fter the infusion, which was later reversed. In accordance, CRF-R2
re generally considered to aid stress recovery upon activation
Bale et al., 2002; Bale and Vale, 2004; Reul and Holsboer, 2002)
nd genetic deletion of CRF-R2 impairs maternal aggression in
actating mice (D’Anna et al., 2008). In contrast, CRF-R2 activation
n the mpBNST of lactating rats is detrimental to maternal behavior
Klampﬂ et al., 2014).
Following stressor exposure, CRF-R1 inhibition tended to
ncrease ABN, indicating that hyper-activation of adBNST CRF-R1
ight be detrimental to maternal care under stressful conditions.
nterestingly, this is in contrast to the mpBNST (Klampﬂ et al., 2014)
here inhibition of CRF-R2 has similar behavioral effects as inhi-
ition of CRF-R1 in the adBNST suggesting that maternal care is
ifferentially regulated by CRF-R in a site speciﬁc-manner: in the
nterior BNST CRF-R1 seems to be the dominant receptor regulating
aternal care, whereas in the posterior BNST CRF-R2 predominate
n modulating maternal care and aggression as well as anxiety-
elated behavior (Klampﬂ et al., 2014).
Maternal motivation was unaffected by any treatment in the
dBNST, similar to the mpBNST (Klampﬂ et al., 2014). This was
nticipated as only the avBNST interconnects with the medial pre-
ptic area, a main site regulating maternal motivation (Numan and
oodside, 2010). Hence, the ad/mpBNST CRF system is evidently
ot involved in maternal motivation in lactating rats.
Maternal aggression was not affected by any CRF-R manipu-
ation in the adBNST, in contrast to the mpBNST where CRF-R2
ctivation abolishes attacking behavior and aggressive encoun-
ers (Klampﬂ et al., 2014). Unlike the adBNST, the mpBNST highly
xpresses Crfr2 mRNA (Klampﬂ et al., 2014) and is implicated in
efensive behaviors (Bosch, 2013; Dong and Swanson, 2004). Given
he CRF-R2 subtype is involved in mediating maternal aggression
D’Anna and Gammie, 2009; Klampﬂ et al., 2014) and Crfr2 mRNA
as not detected in the adBNST, a lack of effect may  underlie the
ehavioral differences resulting from CRF-R manipulation in the
d- and mpBNST.
Anxiety-related behavior was unaffected by CRF-R manipula-
ion in the adBNST. This was unexpected since the BNST CRF system
egulates anxiety (Klampﬂ et al., 2014; Sahuque et al., 2006; Walker
t al., 2003) and CRF-R2 inhibition in the anterolateral BNST is anx-
ogenic in male Fisher-344 rats (Tran et al., 2014). This discrepancy
ay  be a consequence of sex-speciﬁc anxiety regulation (Klampﬂ
t al., 2014; Toufexis, 2007), abnormal HPA axis functioning and/or
xtremely low anxiety levels in male Fisher-344 rats (Tran et al.,
014). Furthermore, it is possible that any effect on anxiety-related
ehavior mediated via CRF-R1 or -R2 in the adBNST is masked due
o the opposing inﬂuence of the oval nucleus and the anterodorsal
ucleus (which were both targeted by the infusions) on anxiety-
elated behavior (Kim et al., 2013). Thus, given the lack of effect of
RF-R manipulation in the adBNST and a strong anxiolytic effect
f CRF-R inhibition in the mpBNST of lactating rats (Klampﬂ et al.,
014), we propose that the anxiety-mediating effects of CRF might
e restricted to the mpBNST during lactation.
The BNST is vital for HPA axis regulation (Crestani et al., 2013)
s well as acutely (Pereira et al., 2015) and chronically (Brummelte
nd Galea, 2010a) elevated CORT levels are detrimental to maternal
are. Here, acute activation of CRF-R1 increased plasma ACTH and
ORT, while activation of CRF-R2 increased ACTH to a lesser extent
han CRF-R1 activation and affected CORT in a stress-dependent
ontext, indicating differential regulation of the HPA axis by the
wo receptor subtypes. Only a small proportion of neurons in the
dBNST, i.e., those in the oval nucleus (Dong et al., 2001b), directly
roject to the PVN, however it is unclear if this pathway plays an
mportant role in mediating the modulatory actions of CRF-R1/R2ocrinology 64 (2016) 89–98
activation in the adBNST on HPA axis activity. An alternative expla-
nation is that the GABAergic projection from the adBNST to the
avBNST plays a more important role. Given avBNST neurons send
GABAergic projections to the PVN CRF neurons (Crestani et al.,
2013; Turesson et al., 2013), activation of adBNST CRF-R1 might
activate the HPA axis via disinhibition of the GABAergic input to
the hypothalamus from the avBNST. As CRF-R1 activation stimu-
lated ACTH secretion to a greater extent than CRF-R2 activation,
and CORT secretion was similarly induced by activation of both
receptors, a dissociation of the hypothalamus/pituitary and adrenal
glands also seems feasible. Thus, following CRF-R2 activation, CORT
secretion might be stimulated via activation of the sympathetic ner-
vous system, rather than driven by the pituitary. This is supported
by studies showing projections from the adBNST to autonomic
brainstem nuclei (Dong et al., 2001b; Herman et al., 2003; Spencer
et al., 2005). Interestingly, CRF-R2 agonist-induced CORT secre-
tion was  markedly reduced following exposure to stress, thus it
appears that CRF-R2 may switch function depending on the pres-
ence or absence of stress. Under basal conditions, CRF-R2 seem to
act in concert with CRF-R1, while under stress conditions, CRF-
R2 assume their well-documented role in terminating the stress
response (Bale et al., 2002; Bale and Vale, 2004). Our data clearly
demonstrates that CRF-R manipulation in the adBNST strongly
inﬂuences HPA axis activity, which could potentially affect mater-
nal care via CORT secretion (Brummelte and Galea, 2010a; Pereira
et al., 2015). Importantly, an acute rise in circulating ACTH and the
concomitant increase in peripheral CORT did not impact mater-
nal care, indicating that the behavioral changes observed following
intra-adBNST CRF-R manipulation are likely centrally mediated,
rather than a result of activation of the peripheral stress axis. It
is unlikely that the dose of ACTH was  too low to induce behavioral
changes given the ACTH infusion and maternal defense, which typi-
cally reduces maternal care (Bayerl et al., 2014; Klampﬂ et al., 2014,
2013), increased CORT concentrations to similar levels.
With respect to peripartum adaptations, Crf mRNA expression in
the adBNST was greater in lactating rats than in virgins, while Crfr1
mRNA expression was not different. Interestingly, similar ﬁndings
were reported on the mpBNST (Klampﬂ et al., 2014; Walker et al.,
2001). Thus, it is likely that hypo-activation of CRF-R1 required
for adequate maternal behavior is achieved by down-regulation of
other CRF-family members. We  did not detect Crfr2 mRNA expres-
sion in the adBNST or avBNST, consistent with ﬁndings in male
and virgin females (Van Pett et al., 2000). Thus, the behavioral and
physiological changes observed after adBNST CRF-R2 manipula-
tion may  have been mediated via an adjacent brain region e.g., the
lateral septum, which abundantly expresses Crfr2 mRNA (Potter
et al., 1994). In particular, the ventral septal region exhibits bidi-
rectional connections with the PVN (Risold and Swanson, 1997)
and might therefore account for the HPA axis activation follow-
ing CRF-R2 manipulation. We  can exclude diffusion to the mpBNST
due to the different behavioral effects of CRF-R2 activation in the
adBNST versus the mpBNST (Klampﬂ et al., 2014). Moreover it
is unlikely that the CRF-R2 agonist is acting on CRF-R1, given it
is highly selective for CRF-R2 (Hsu and Hsueh, 2001; Lim et al.,
2005). Although Crfr2 mRNA expression was not detected in the
adBNST, the receptor may  be expressed on presynaptic nerve ter-
minals in the adBNST arising from other brain regions. Indeed there
is evidence that CRF-R2-immunoreactive ﬁbers in the BNST origi-
nate from the PVN (Dabrowska et al., 2011). This could explain the
behavioral/physiological effects of CRF-R2 manipulation, despite a
lack of mRNA expression.
The present ﬁndings together with the mpBNST data (Klampﬂ
et al., 2014) demonstrate the tremendous heterogeneity of the
BNST sub-regions in terms of behavior modulation by one
neuropeptide family. Different behavioral outcomes of CRF-R
manipulation in the ad- and mpBNST may  be explained by different
uroend
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nputs and projection sites in the respective divisions (Dong et al.,
001a,b; Dong and Swanson, 2004). Importantly, the anterior and
osterior divisions of the BNST also vary in the distribution of CRF
amily members. CRF-ir cell bodies, ﬁbres and nerve terminals are
oncentrated within the anterior BNST (Ju et al., 1989), whereas
rocortin 3 (CRF-R2 ligand) is primarily found in the posterior part
Li et al., 2002). These different neuroanatomical/neurochemical
roﬁles may  underpin differential effects of CRF-R manipulation
n maternal behavior depending on the site of action.
In conclusion, manipulation of the BNST CRF system exerted
ifferential effects on maternal and anxiety-related behavior in
n anterior-posterior fashion, independent of HPA axis activation.
hese results demonstrate the complexity of maternal neuro-
hysiology and provide new insights into the potential causes of
isturbed maternal behavior postpartum.
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